A Single‐Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal Cancer

LESSONS LEARNED. Patients with metastatic colorectal cancer with good performance status or no liver metastasis could benefit from apatinib. Circulating tumor DNA abundance may be a predictor in serial monitoring of tumor load. BACKGROUND. Apatinib, an oral vascular endothelial growth factor (VEGF)...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: Chen, Xiaofeng, Qiu, Tianzhu, Zhu, Yingwei, Sun, Jing, Li, Ping, Wang, Biao, Lin, Peinan, Cai, Xiaomin, Han, Xiao, Zhao, Fengjiao, Shu, Yongqian, Chang, Lianpeng, Jiang, Hua, Gu, Yanhong
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2019
Soggetti:
Clinical Trial Results
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656475/
https://ncbi.nlm.nih.gov/pubmed/30877190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0164
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi